Next report date
Report period
Q1 2024
EPS estimate
−0.54USD
Revenue estimate
—
−1.92USD
−73.63 MUSD
805.11 KUSD
35.70 M
About Barinthus Biotherapeutics plc
Sector
CEO
William Enright
Headquarters
Didcot
Website
Employees (FY)
130
Founded
2021
FIGI
BBG00ZZPCP09
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
